Cytok is a startup based in Germany. Brouky records 1 investor associated with the company.
Cytok is a German biotech company developing innovative allogeneic CAR-T cell therapies for cancer patients. Their lead product, CYT-101, is designed to target solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.